Form 4: Molina Healthcare Executive Reports Routine Stock Transactions and Future Equity Vesting
Insider Transaction Report
Molina Healthcare's EVP of Medicaid, Debra Bacon, reported recent stock acquisitions through an employee plan and dispositions for tax withholding, alongside a detailed future vesting schedule for her equity holdings.
Summary
- Debra Bacon, EVP, Medicaid, acquired 41 shares of Molina Healthcare Common Stock on June 30, 2025, at a price of $247.39 per share, through the 2019 Employee Stock Purchase Plan (ESPP).
- The ESPP purchase price of $247.39 represents 85% of the lower market price between January 1, 2025 ($291.05) and June 30, 2025.
- On July 1, 2025, 183 shares were disposed of at $306.29 per share to cover withholding taxes arising from the vesting of 530 shares.
- Following these transactions, Debra Bacon beneficially owns 12,884 shares of Common Stock.
- A portion of the shares are scheduled to vest: 2,021 shares on March 1, 2026; 529 shares on July 1, 2026; 1,775 shares on March 1, 2027; and 1,018 shares on March 1, 2028.
Sentiment
Score: 6
Explanation: The document is a routine Form 4 filing detailing executive stock transactions. The acquisition through an ESPP is a minor positive, indicating continued executive investment, while the disposition for tax purposes is neutral. No significant positive or negative operational or financial news is conveyed.
Positives
- Acquisition of shares through an Employee Stock Purchase Plan indicates continued investment and alignment of executive interests with shareholders.
- The ESPP purchase price of $247.39 was at a discount (85%) to the market price, providing an immediate benefit to the executive.
Negatives
- Disposition of 183 shares for tax withholding reduces the executive's direct beneficial ownership.
Future Outlook
The document details future vesting schedules for a significant portion of the executive's equity, indicating a long-term incentive structure for key management.
Management Comments
- The shares were acquired under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan (the 'ESPP').
- In accordance with the ESPP, the purchase price is 85% of the closing price of the Issuer's common stock on January 1, 2025 of $291.05 (which represents the lower market price of the Issuer's common stock as of (i) January 1, 2025, the first date of the ESPP offering period, and (ii) June 30, 2025, the last trading day of the offering period).
- The shares were applied to the payment of withholding taxes arising in connection with the vesting of 530 shares on July 1, 2025.
- The shares vest as follows: 2,021 shares on March 1, 2026; 529 shares on July 1, 2026; 1,775 shares on March 1, 2027; and 1,018 shares on March 1, 2028. The remaining shares are vested.
Industry Context
This Form 4 filing reflects routine insider stock transactions common in publicly traded companies, particularly related to executive compensation plans like Employee Stock Purchase Plans and equity vesting. Such transactions are standard practice for aligning executive incentives with shareholder value in the healthcare services industry.
Comparison to Industry Standards
- The use of an Employee Stock Purchase Plan (ESPP) and equity vesting schedules for executive compensation is a common practice across the healthcare industry and broader corporate landscape.
- Companies like UnitedHealth Group (UNH), Anthem (now Elevance Health, ELV), and Centene (CNC) also utilize similar equity-based compensation structures to incentivize long-term performance and retain key talent.
- The specific discount rate (85%) offered in the ESPP is within typical industry ranges, which often vary from 85% to 95% of the market price.
- The disposition of shares for tax withholding upon vesting is also a standard procedure for managing tax obligations on equity compensation.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Appointment | Debra Bacon appointed Jeff D. Barlow and Codruta Boggs as attorneys-in-fact for Section 16(a) filings (Forms 3, 4, and 5) with the SEC. | 2024-01-26 | Streamlines the process for executive compliance with SEC reporting requirements for insider transactions. |
Stakeholder Impact
- Shareholders: The executive's participation in the ESPP and long-term vesting schedule aligns her interests with shareholder value creation. The disposition for tax purposes is a routine event and does not indicate a change in strategy.
- Employees: The existence of an ESPP suggests a broader employee benefit program, potentially fostering employee ownership and engagement.
Next Steps
- Monitoring future vesting events for Debra Bacon's equity holdings on March 1, 2026, July 1, 2026, March 1, 2027, and March 1, 2028.
Key Dates
| Date | Description |
|---|---|
| 2024-01-26 | Date of Limited Power of Attorney for Section 16(a) filings. |
| 2025-01-01 | First date of the ESPP offering period, with a closing price of $291.05. |
| 2025-06-30 | Last trading day of the ESPP offering period; date of acquisition of 41 shares under ESPP. |
| 2025-07-01 | Date of disposition of 183 shares for tax withholding and vesting of 530 shares. |
| 2025-07-02 | Date the Form 4 was signed by power of attorney. |
| 2026-03-01 | Vesting date for 2,021 shares. |
| 2026-07-01 | Vesting date for 529 shares. |
| 2027-03-01 | Vesting date for 1,775 shares. |
| 2028-03-01 | Vesting date for 1,018 shares. |
Recommendation
holdKeywords
Molina Healthcare, MOH, SEC Form 4, insider trading, stock transactions, employee stock purchase plan, equity vesting, executive compensation, Debra Bacon
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.